DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays

  • Amrit Singh
    University of British Columbia Prevention of Organ Failure (PROOF) Centre of Excellence, , Vancouver, BC, Canada
  • Casey P Shannon
    University of British Columbia Prevention of Organ Failure (PROOF) Centre of Excellence, , Vancouver, BC, Canada
  • Benoît Gautier
    University of Queensland Diamantina Institute, Translational Research Institute The , Woolloongabba, Queensland, Australia
  • Florian Rohart
    Institute for Molecular Bioscience, The University of Queensland , St Lucia, Queensland, Australia
  • Michaël Vacher
    Australian eHealth Research Centre, Commonwealth Scientific and Industrial Research Organisation , Brisbane, Queensland, Australia
  • Scott J Tebbutt
    University of British Columbia Prevention of Organ Failure (PROOF) Centre of Excellence, , Vancouver, BC, Canada
  • Kim-Anh Lê Cao
    Melbourne Integrative Genomics, School of Mathematics and Statistics, The University of Melbourne , Melbourne, Australia

説明

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Motivation</jats:title> <jats:p>In the continuously expanding omics era, novel computational and statistical strategies are needed for data integration and identification of biomarkers and molecular signatures. We present Data Integration Analysis for Biomarker discovery using Latent cOmponents (DIABLO), a multi-omics integrative method that seeks for common information across different data types through the selection of a subset of molecular features, while discriminating between multiple phenotypic groups.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Using simulations and benchmark multi-omics studies, we show that DIABLO identifies features with superior biological relevance compared with existing unsupervised integrative methods, while achieving predictive performance comparable to state-of-the-art supervised approaches. DIABLO is versatile, allowing for modular-based analyses and cross-over study designs. In two case studies, DIABLO identified both known and novel multi-omics biomarkers consisting of mRNAs, miRNAs, CpGs, proteins and metabolites.</jats:p> </jats:sec> <jats:sec> <jats:title>Availability and implementation</jats:title> <jats:p>DIABLO is implemented in the mixOmics R Bioconductor package with functions for parameters’ choice and visualization to assist in the interpretation of the integrative analyses, along with tutorials on http://mixomics.org and in our Bioconductor vignette.</jats:p> </jats:sec> <jats:sec> <jats:title>Supplementary information</jats:title> <jats:p>Supplementary data are available at Bioinformatics online.</jats:p> </jats:sec>

収録刊行物

  • Bioinformatics

    Bioinformatics 35 (17), 3055-3062, 2019-01-18

    Oxford University Press (OUP)

被引用文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ